Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 408 Rectal Neoplasms 152 Colonic Neoplasms 150 Pancreatic Neoplasms 114 Stomach Neoplasms 110 Neoplasm Metastasis 70 Esophageal Neoplasms 60 Esophageal Squamous Cell Carcinoma 33 Neoplasms 31 Adenocarcinoma Of Esophagus 27 Gastrointestinal Neoplasms 17 Cholangiocarcinoma 14 Biliary Tract Neoplasms 14 Gallbladder Neoplasms 12 Carcinoma, Hepatocellular 12 Adenocarcinoma 12 Colorectal Cancer Metastatic 11 Carcinoma, Non-Small-Cell Lung 11 Breast Neoplasms 11 Liver Neoplasms 10 Digestive System Neoplasms 10 Ovarian Neoplasms 9 Small Cell Lung Carcinoma 8 Locally Advanced Rectal Cancer 8 Intestinal Neoplasms 8 Bile Duct Neoplasms 8 Carcinoma 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Digestive System Diseases 6 Appendiceal Neoplasms 6

Interventions

apatinib 9 Paclitaxel 9 Capecitabine 7 Oxaliplatin 6 camrelizumab 5 Cisplatin 5 S 1 (combination) 4 Fluorouracil 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 Drug Therapy 2 vorolanib 1 trifluridine tipiracil drug combination 1 tipiracil 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 ezogabine 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric Cancer × Irinotecan × Gastrointestinal × Clear all

NCT01136031 2015-05-20

TI-2ndAGC

Seoul National University Hospital

Phase 1/2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡